STOCK TITAN

Iveda Solutions, Inc. Form 4 Filings

IVDA NASDAQ

Every Form 4 that Iveda Solutions, Inc. (IVDA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow IVDA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IVDA filings page.

Rhea-AI Summary

Iveda Solutions director Robert Gillen reported offsetting option transactions tied to an option repricing. He was granted 100,000 stock options on an "acquire" transaction and disposed of 100,000 options back to the issuer on a separate "disposition to issuer" transaction, leaving 128,599 options reported as held afterward.

According to a board-approved repricing on February 23, 2026, his options were reset to an exercise price of $0.29 per share while all other terms remained unchanged. The company states these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.

Rhea-AI Summary

Iveda Solutions Chief Financial Officer Robert J. Brilon reported changes to his stock options in a paired, non-cash transaction. He was granted 125,000 options and disposed of 125,000 options, both recorded as “Options (Right to Buy).” Following these transactions, he holds 152,503 derivative securities directly.

The company’s board approved an option repricing on February 23, 2026, resetting the exercise price of his options to $0.29 per share. The filing states that all other option terms remain unchanged and that the repricing was exempt under specific Exchange Act rules.

Rhea-AI Summary

Iveda Solutions director Franco Alejandro reported an option repricing and related award. On February 23, 2026, the board approved a repricing of his options to an exercise price of $0.29 per share, with all other terms unchanged. This involved an acquisition of 25,000 options and a corresponding disposition of 25,000 options to the issuer, both recorded at a transaction price of $0.00 per option. Following these transactions, Alejandro directly held 53,130 options to acquire Iveda Solutions stock. The company notes these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.

Rhea-AI Summary

Iveda Solutions, Inc. reported that Chief Executive Officer David H. Ly had his stock options repriced by the board. On February 23, 2026, options covering 175,000 shares were granted or awarded, and a separate 175,000-option position was disposed of back to the issuer. According to the disclosure, the repricing set the exercise price at $0.29 per share, while all other option terms remained unchanged. After these offsetting derivative transactions, Ly directly held options to acquire 216,096 shares.

Rhea-AI Summary

Iveda Solutions director Joseph A. Farnsworth reported option transactions tied to an option repricing. On February 23, 2026, he acquired 100,000 stock options at an exercise price of $0.29 per share and disposed of 100,000 options back to the company, with other option terms remaining unchanged.

Rhea-AI Summary

Iveda Solutions (IVDA) director reports share disposition. A Form 4 shows a director disposed of 20,331 shares of common stock on 10/21/2025 at a price of $1.28 per share. Following the transaction, the reported beneficial ownership was 0 shares, held directly. The form was signed by Robert D. Gillen.